Pfizer : Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting
Pfizer Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting Wednesday, May 29, 2024 - 12:30pm ...
Stay updated with breaking news from Chris Boshoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting Wednesday, May 29, 2024 - 12:30pm ...
PFE earnings call for the period ending March 31, 2024.
U.S. futures are down as a busy earnings season continues and investors await an interest rate decision from the Fed.
PFE earnings call for the period ending March 31, 2024.
Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (tisotumab vedotin-tftv) for the treat